A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP)
Clinical trial NCT03275454 · COMPLETED
Trial details
- NCT number
- NCT03275454
- Sponsor
- Bioverativ, a Sanofi company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-14
- Primary completion
- 2021-02-16
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.